Menu
Live News EQUITY M impact

LFMD: Launches Self-Pay Program

LifeMD announces exclusive collaboration to launch direct-to-patient self-pay program for XYOSTED injection

LFMDLFMDP

LFMD LFMDP - LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection